Natural uranium is an ubiquitous element present in the environment and human exposure to low levels of uranium is unavoidable. Although the main target of acute uranium toxicity is the kidney, some concerns have been recently raised about neurological effects of chronic exposure to low levels of uranium. Only very few studies have addressed the molecular mechanisms of uranium neurotoxicity, indicating that the cholinergic and dopaminergic systems could be altered. The main objective of this study was to investigate the mechanisms of natural uranium toxicity, after 7-day continuous exposure, on terminally differentiated human SH-SY5Y cells exhibiting a dopaminergic phenotype. Cell viability was first assessed showing that uranium cytotoxicity only occurred at high exposure concentrations (> 125 μM), far from the expected values for uranium in the blood even after occupational exposure. SH-SY5Y differentiated cells were then continuously exposed to 1, 10, 125 or 250 μM of natural uranium for 7 days and uranium quantitative subcellular distribution was investigated by means of micro-PIXE (Particle Induced X-ray Emission). The subcellular element imaging revealed that uranium was located in defined perinuclear regions of the cytoplasm, suggesting its accumulation in organelles. Uranium was not detected in the nucleus of the differentiated cells. Quantitative analysis evidenced a very low intracellular uranium content at non-cytotoxic levels of exposure (1 and 10 μM). At higher levels of exposure (125 and 250 μM), when cytotoxic effects begin, a larger and disproportional intracellular accumulation of uranium was observed. Finally the expression of dopamine-related genes was quantified using real time qRT-PCR. The expression of monoamine oxidase B (MAO-B) gene was statistically significantly decreased after exposure to uranium while other dopamine-related genes were not modified. The down regulation of MAO-B was confirmed at the protein level. This original result suggests that the inhibition of dopamine catabolism, but also of other MAO-B substrates, could constitute selective effects of uranium neurotoxicity.
Introduction
Uranium is a natural weakly radioactive element with adverse health effects mainly due to its chemical rather than radiological toxicity (Keith et al., 2008; ATSDR, 2013) . Uranium occurs naturally in the environment, existing in nearly all rocks and soils with a typical abundance of 2-4 μg.g . This ubiquitous presence results in continuous human exposure to low uranium concentrations mainly through ingestion. The intake through food and water consumption is approximately 0.9-1.5 μg/day for most of the population. Higher exposure levels may be found in geographical areas with elevated levels of naturally occurring uranium, increasing uranium content in food, or in https://doi.org/10.1016/j.neuro.2018.07.019 Received 4 May 2018; Received in revised form 26 July 2018; Accepted 30 July 2018 the water especially when ground water is used for drinking. In some regions of the world, uranium in ground water can reach values most above the 30 μg.L −1 WHO recommended guideline for drinking water quality (Frisbie et al., 2009; WHO, 2011) . Moreover, the WHO recommended guideline for uranium in drinking water is only provisional and a matter of debate since it might not be fully protective (Frisbie et al., 2013; Ansoborlo et al., 2015) . The highest human exposures occur in occupational settings, in uranium milling and processing industries, or for people working with phosphate fertilizers (ATSDR, 2013) . Recently human exposure also involves military use of depleted uranium weapons (ATSDR, 2013) . In case of high uranium exposure, the main targets of uranium toxicity in human are the kidneys and the bones where it accumulates for years. Less severe effects are however observed on the liver, lungs, reproductive and nervous systems (Keith et al., 2008; ATSDR, 2013) . In the last few years, several studies have clearly pointed out that the brain is a sensitive target for uranium toxicity (reviewed in Dinocourt et al., 2015) . Uranium exposure induces neurobehavioral changes such as increased locomotor activity, perturbation of the sleep-wake cycle, decreased memory, and increased anxiety on animal models. The mechanisms by which uranium induces neurological alterations are not fully known. Changes in levels of neurotransmitters and their metabolites involved in acetylcholine and dopaminergic pathways have been observed in animal brains after exposure to uranium (Bussy et al., 2006; Barber et al., 2007; Briner et al., 2008; Bensoussan et al., 2009) . Further studies are needed to better understand the mechanisms of action for uranium-induced neurological effects. Such data are required to evaluate whether long-term exposure to low uranium concentrations could affect neurological functions in humans especially to populations continuously exposed to excessive uranium in the drinking water or in the food.
Most of the existing studies on uranium-induced toxicity involved rodent models. Data on uranium toxicity thresholds or on molecular mechanisms of neurotoxicity in human are still scarce. Here we selected the human SH-SY5Y cell line as study model. Human SH-SY5Y cells are frequently used as in vitro neuronal model since these cells may acquire a catecholaminergic neuronal phenotype with pronounced dopaminergic characteristics after a differentiation step (Presgraves et al., 2004) . A 7-day period of continuous uranium exposure was selected in order to approach in vitro the conditions inducing molecular effects more specific to continuous rather than acute exposures. By using this cellular model and with this exposure condition, we have recently evidenced the isotopic fractionation of uranium suggesting the existence of a high affinity transporter protein for uranium uptake (Paredes et al., 2016 (Paredes et al., , 2018 . In the present study we addressed the question of uranium intracellular distribution using Particle Induced Xray Emission (PIXE) chemical element imaging. At high exposure concentrations (i.e. 300 μM of more) uranium is known to form insoluble precipitates with needle shapes located in intracellular vesicles as observed with different cellular models (Carrière et al., 2006; Carrière et al., 2008; Pierrefite-Carle et al., 2017) . Only very few studies have addressed the intracellular distribution of uranium at lower exposure concentrations before it forms precipitates. Controversial results were obtained since in the one hand, uranium was found only in the nucleus of the cells (Rouas et al., 2010; Guéguen et al., 2015) , while in the other hand uranium was found in defined regions of the cytoplasm (HommaTakeda et al., 2015) . Only one study reported uranium distribution in neuron-like cells (Rouas et al., 2010) .
The aim of this study was to investigate the mechanisms of natural uranium neurotoxicity on human dopaminergic cells continuously exposed to uranium during 7 days. The cytotoxic concentration threshold was first evaluated. Then the intracellular distribution of uranium was assessed at representative exposure concentrations: below (10 μM), close to (125 μM) and above (250 μM) cytotoxic threshold. In addition, by using real time quantitative reverse transcription PCR (RT-qRT-PCR) and enzyme-linked immunosorbent assays our study brings original results on the interaction of uranium with the expression of dopaminerelated genes and proteins in human cells.
Material and methods

Reagents and solutions
Eagle's minimum essential medium (EMEM, 30-2003; ATCC) , F12 medium (21765-029; Life Technologies), fetal bovine serum FBS (30-2020; ATCC), and penicillin/streptomycin (15070-063; GibcoThermo Fisher Scientific) solutions were used to prepare the culture medium for cell growth and exposure experiments. TrypLE Express 1×/EDTA (12605-010; Gibco-Thermo Fisher Scientific) was used for the trypsinization of cells. PBS (pH 7.4) free of CaCl 2 and MgCl 2 (10010-015; Gibco-Thermo Fisher Scientific) was used to wash the cells after trypsinization. Retinoic acid (RA) and 12-O-tetradecanoylphorbol-13-acetate (TPA) used for cell differentiation were purchased from Sigma-Aldrich (R2625 and P8139, respectively). A 3 mg.mL −1 RA solution was prepared in sterile dimethyl sulfoxide (DMSO, Sigma-Aldrich) under a nitrogen atmosphere in opaque tubes and stored at −80°C. TPA was re-suspended at 1 mg.mL −1 in sterile DMSO, and the solution was stored at −20°C.
Cells and dopaminergic differentiation
SH-SY5Y human neuroblastoma cells were purchased from ATCC USA (CRL-2266 ™ , Lot 59,740,436). Cells were cultured according to ATCC guidelines. To obtain an effective cellular differentiation it is required to use the cell culture reagents and the fetal bovine serum (FBS) recommended by ATCC. The complete growth medium consisted in a 1:1 EMEM (ATCC), and F12 Medium (Sigma-Aldrich), supplemented with 10% high quality FBS not heat-inactivated (ATCC), 100 μg.mL −1 penicillin, 100 μg.mL −1 streptomycin (Gibco-Thermo Fisher Scientific). Complete growth medium was renewed every 3 to 4 days. Cells were cultured at 37°C in air with 5% carbon dioxide. SH-SY5Y cells were terminally differentiated into dopaminergic neuronlike cells according to the protocol of Presgraves et al. (2004) (Table 1) . In brief, one day after seeding at 25,000 cells cm -2 , cells were first treated with 10 μM RA (Sigma-Aldrich) during 2.5 days. Then the medium was renewed using fresh complete growth medium with 80 nM TPA (Sigma-Aldrich) and cells were cultured for 3.5 days. In order to control that the dopaminergic phenotype was correctly induced, the expression of tyrosine hydroxylase was evaluated by Western blot analysis. Live cell imaging and cryo-fixation A. Carmona et al. Neurotoxicology 68 (2018) 177-188 2.3. Western blot analysis of tyrosine hydroxylase
Western blots were performed as described earlier (Malard et al., 2009) . After 7 days of differentiation, the cells were trypsinized, washed with PBS, then incubated with RIPA buffer (Santa Cruz) containing protease inhibitor cocktail tablet (Complete EDTA free TM Roche) and phosphatase inhibitor (Cocktail I and II, Sigma-Aldrich). The cellular extracts were lysed using a Dounce homogenizer (20 strokes), incubated on ice for 60 min, and then centrifuged at 16,000 g for 60 min. The protein content of the supernatants was determined with the Coomassie Protein Assay (Thermo Scientific). Proteins were separated on a 4-12% NuPAGE® Bis-Tris gel (Invitrogen) in a MOPS/ SDS Running Buffer (Invitrogen) at 200 V. Proteins from the gel were electroblotted on a 0.45 μm PVDF membrane (Thermo Scientific) using a semi-dry electroblot system (Biometra). After a saturation step in milk 5%, the membrane was incubated overnight at 4°C in a 5% milk solution containing a polyclonal Antibody Rabbit anti-Tyrosine Hydroxylase (1/1000, cat# AB152, Millipore). Primary antibody was then detected using an Anti-Rabbit HRP (1/10000, Sigma-Aldrich; A6154). A mouse monoclonal anti-human actin (A3854 Sigma-Aldrich) was used as a control at 1/25,000. The signals were revealed using the Western Chemiluminescent HRP substrate from Millipore.
Preparation of the uranium exposure solution
In-house (Laboratoire de développement Analytique, Nucléaire, Isotopique et Elémentaire (LANIE), DEN, CEA Saclay) natural uranium oxide powder U 3 O 8 was dissolved in 0.5 M ultrapure HNO 3 (SCP Science) to obtain a stock solution at uranium concentration of 151 mM. Uranium concentration was determined by quadrupole Inductively Coupled Plasma Mass Spectrometry (ICP-MS, X7 Series; Thermo Fisher Scientific). The natural uranium stock solution was characterized by a δ238 value of +0.66 ± 0.12‰ (2σ, n = 7) relative to the certified n(238U)/n(235U) of IRMM-184 material. This solution was diluted into a buffer, made of 0.1 mol. 
Cell exposure to uranium
The workflow for SH-SY5Y cell culture, differentiation and uranium exposure on sample holders for micro-PIXE experiments is summarized in Table 1 . Sample holders for micro-PIXE consist in a thin (2 μm) ultrapure polycarbonate film stretched over a plastic frame with a 5 mm x 5 mm window where cells are grown. Sample holders were sterilized in analytical grade ethanol, rinsed with ultrapure water and dried in sterile conditions. To enhance cell attachment, polycarbonate films were coated with a solution of 0.01 mg.mL −1 of bovine serum albumin, 0.01 mg.mL −1 of human fibronectin, and 0.03 mg.mL −1 of collagen type I (all products from Sigma-Aldrich) prepared in complete growth medium. Before cell seeding onto polycarbonate films, SH-SY5Y cells were first cultured in plastic flasks for 10 days after thawing following standard methods as described before. At day 0 (Table 1) , SH-SY5Y cells were harvested, counted, and 10 4 cells. cm -2 seeded onto each micro-PIXE sample holder. Cells were thereafter grown on polycarbonate films, differentiated with RA-TPA during 7 days and exposed to defined concentrations of natural uranium for 7 days more. Uranium exposure solutions at 1, 10, 125 and 250 μM were selected according to the cytotoxicity assay results and prepared in complete cell growth medium by dilution of the 30 mM intermediate uranium solution. Uranium content after dilution in the culture medium was measured systematically by ICPMS to verify that the exposure solutions contained the expected U concentrations.
Cytotoxicity studies
The cytotoxic potential of uranium on differentiated SH-SY5Y cells was investigated by the CellTiter-Glo® Luminescence Cell Viability Assay, an in vitro test that allows the measurement of the amount of intracellular ATP, which is directly linked to the number of metabolically active cells. Briefly, SH-SY5Y cells were plated at the same density and conditions as described above. After differentiation, uranium toxicity was assessed between 0 μM to 500 μM and Triton 1% was used as a positive control. At the end of the exposure (7 days), the Promega CellTiter-Glo reagent was added and after 20 min incubation, luminescence was measured on a luminescence plate reader (LumiStar, BMG) with a 5 s integrated reading. For each experimental point, four independent assays were carried out, each performed in sextuplate. Values were expressed as percentage of viability following the formula [(mean luminescence for a given sample condition/mean luminescence of unexposed cells)]. Data are presented as the mean ± SD. The Prism6 software (GraphPad software) was used to calculate IC values.
Sample preparation for micro-PIXE experiments
The protocol for sample preparation was adapted from recently optimized methods for element imaging in single cells using micro-PIXE (Perrin et al., 2015) . At day 15 (Table 1) , SH-SY5Y terminally differentiated cells were labeled with a fluorescent nuclear dye, Hoechst 33342, in order to perform correlative imaging of nucleus position in single cells with element distributions, as previously described . Similarly, to label the lysosomes and Golgi apparatus cells were transduced with CellLight® lysosomes (Invitrogen) red fluorescent reagent and with CellLight® Golgi (Invitrogen) green fluorescent reagent according to previously published protocols . In addition some preparations of cells labeled with the CellLight® Golgi were exposed to 20 μg.mL −1 of brefeldin A (Sigma Aldrich), a chemical disruptor of the Golgi apparatus (Carmona et al., 2010) . Live cell imaging of the nuclear, lysosome or the Golgi apparatus fluorescence was recorded with an epifluorescence microscope (Olympus BX51). Immediately after live cell microscopy, cells were rinsed with a 150 mM ammonium acetate buffer solution, pH 7.4, prepared in ultrapure water (Fisher) to remove traces of extracellular ions. Then cells were cryofixed by plunge freezing in isopentane chilled with liquid nitrogen down to -160°C, and freeze-dried at −90°C under primary vacuum (Christ Alpha 1-4 freeze drier). After 3 days of freeze drying, samples were slowly brought back to room temperature and ambient pressure. Samples were stored into a desiccator dry box until analysis.
Micro-PIXE analyses and data treatment
Micro-PIXE analyses were carried out at AIFIRA facility (Applications Interdisciplinaires des Faisceaux d'Ions en Région Aquitaine) (Sorieul et al., 2014) . AIFIRA ion beam facility is based on a 3.5 MV Singletron particle accelerator (HVEE, The Netherlands). The Singletron accelerator provided a 3.0 MeV proton beam that was focused down to 800 nm beam size using the high spatial resolution beamline resulting in a 0.5 nA beam current. Uranium and the other chemical elements were mapped at the single cell level by performing micro-PIXE as recently reported . Single cells exposed to 0 (number of analyses, n = 8), 1 μM (n = 5), 10 μM (n = 18), 125 μM (n = 26) and 250 μM (n = 13) of uranium were analyzed. Quantification of element content in subcellular regions was obtained by extracting PIXE data from selected areas of the chemical maps (i.e. nucleus and cytoplasm). The exact location of the subcellular areas was defined thanks to the epifluorescence images evidencing the nucleus position in each cell following a correlative PIXE/epifluorescence microscopy approach . Calibration of the X-ray detectors was performed using Micromatter ™ XRF calibration standards. Quantitative data treatment of PIXE spectra was performed using the GUPIXWIN software (Campbell et al., 2010) . This software allows determining the element content and to precisely calculate detection limits. Charge normalization of PIXE data was obtained by performing simultaneously Rutherford Backscattering Spectrometry (RBS) following a methodology described in earlier publications (Carmona et al., 2008) . The accuracy of the chemical elements quantification was checked by analyzing in the same conditions a 10 μm section of the European Reference Material EC681k, as already described (Perrin et al., 2015) . Due to the low intracellular concentrations of uranium, long acquisition times were required to map uranium distributions in single cells, from 4 h to 12 h per cell for the lower uranium exposure condition. In total the micro-PIXE analyses exceeded 500 h of beam time.
RNA extraction and RT-qRT-PCR
Total RNA was isolated using the Qiagen RNeasy miniprep kit (Qiagen) according to the manufacturer's instructions. RNA concentration and purity were determined by OD measurement on a nanodrop 2000 spectrophotometer (Thermo Ficher Scientific). We obtained A260/A280 ratios in the range 1.9-2.1. 1 μg of total RNA was retro-transcribed using the iScript™ Reverse Transcription Supermix for RT-qRT-PCR (Biorad) according manufacturer's instructions. Primers used for RT-qRT-PCR (Biorad) are described in Table S1 , the primer's efficiency was controlled by the supplier. The quantitative RT-qRT-PCR was performed using SYBRgreen (Sso advanced universal SyBr Green supermix, Biorad) on a C1000 touch thermal cycler of Biorad (CFX96 Real Time System), according to the manufacturer's instructions, as follows: activation 2 min at 95°C, 40 cycles of denaturation (5 s at 95°C), 40 cycles of annealing (30 s at 60°C). Melting curve analysis was performed for verifying specificity of each primer after PCR, 5 s/step at 65°C-95°C (0.5°C increments), to ensure amplification specificity. Controls without template were included to verify that fluorescence was not overestimated from primer dimer formation or PCR contaminations. RT-qRT-PCR products were analyzed in a post amplification fusion curve to ensure that a single amplicon was obtained. Normalization for RNA quantity, and reverse transcriptase efficiency was performed against two reference genes, glyceraldehyde 3-phosphate dehydrogenase (hGAPDH) and β Actin (hACTB). For each experimental point, 3 independent assays were carried out, each performed in triplicate. Relative quantification was calculated using the ΔΔCt method which was normalized to the reference genes. All data were analyzed by the Bio-Rad CFX Manager 3.1 software using the gene study function. Relative normalized expression, change in expression relative to control samples, and p value were calculated.
Enzyme-linked immunosorbent assay (ELISA)
SH-SY5Y cells were seeded in 75 cm² flasks at 25.000 cells/cm² density. Cells were differentiated and exposed to uranium according to the protocols described in previous sections. The cell lysate was then prepared according to the following procedure. After being detached by means of 0.25% Trypsine/EDTA solution, cells were collected and centrifuged at 2200 rpm for 5 min in 15 mL test tube. The supernatant was discarded, followed by the addition of 5 mL cold PBS. After a second centrifuge run at 2200 rpm for 5 min, PBS was once again discarded leaving the pellet in 500 μL of solution. A protease inhibitor cocktail (Sigma Aldrich) was added at 1 μL per 100 μL of homogenate buffer. The cells were lysed by mechanical stress using a minipotter and solutions were transferred in 1.5 mL tubes. Finally, after 30 min centrifuge at 30,000 g the supernatants were collected. Thirty μL aliquots for each sample were used fresh to perform the total protein extract quantification by means of bicinchoninic acid protein assay kit (Sigma Aldrich). The remaining solutions were stored overnight at −20°C in order to proceed with the MAO-B quantification the day after. The concentration of MAO-B in cell extracts was determined by measuring the absorbance at 450 nm using a commercial MAO-B ELISA kit (Aviva System Biology). In brief, the cell lysate (5 μL) was preliminary diluted in 95 μl of PBS. A final dilution (1/5 ratio in volume) using kit sample diluent was performed. A final volume of 100 μL was added in each well of the ELISA plate. After incubation at 37°C for 2 h, a second incubation with 100 μL per well of biotinylated MAO-B detector antibody for 1 h at 37°C was carried out. Then, all the wells were washed three times with the kit washing buffer (300 μL). A third incubation with 100 μL per well of avidin-horse radish peroxidase conjugate (1 h at 37 C) was then followed by five times washing (300 μL) steps. Finally, 90 μL of TMB (3,3′,5,5′-Tetramethylbenzidine) substrate was added to each well. The plate was then incubated at 37°C for 15 min in the dark. In order to block the reaction, the stop solution (50 μL) was added to each well, and the absorbance was read at 450 nm within 5 min. The concentrations of MAO-B in the corresponding cell extracts were calculated according to the standard calibration curve prepared following the kit instructions. Data were expressed in picograms of MAO-B for milliliter of solution. The results were then normalized according the total protein extract concentrations and reported as MAO-B micrograms per total milligrams of protein extract. In order to have a consistent statistics, three biological replicates were carried out, each was measured in triplicate by ELISA. Statistical analysis was performed by means of R software version 3.4.4 (R Core Team, 2018). Analysis of variance (ANOVA) with Tukey post hoc test was used to examine differences between groups after checking the normality of the distribution (Shapiro-Wilk normality test) and the homogeneity of variance (Levene test).
Results and discussion
Induction of a dopaminergic phenotype in SH-SY5Y cells
Since uranium has potential toxicity towards dopamine metabolism (Bussy 2006 , Barber 2007 , Briner, 2008 , we chose differentiated SH-SY5Y as a representative model of human dopaminergic neurons to study uranium-related neurotoxicity. The SH-SY5Y cell line is frequently used as in vitro model of catechoalaminergic neurons (Presgraves 2004, Kovalevich and Langford, 2013; Westerink, 2013) , in particular for metal-induced neuronal toxicity studies (Stephenson et al., 2013; Branca et al., 2018) . It is necessary to stimulate their differentiation using various agents, such as RA and TPA, into a more characteristically dopaminergic neuronal phenotype (Presgraves 2004 , Barbosa 2014 . However, culture conditions, cell source and differentiation protocol may vary. A recent review of the use of SH-SY5Y cells as a model for Parkinson's disease described the variability of these parameters in the published literature (Xicoy 2017). We selected cells from ATCC for thisworkand compared differentiation with RA alone (data not shown) or in combination with TPA (Fig. 1) . Our results showed that only the combination of RA and TPA induced the overexpression of tyrosine hydroxylase (TH), confirming the results obtained by Presgraves et al. (2004) . In their study, Presgraves et al. (2004) described in detail and compared the phenotypes of SH-SY5Y cells after differentiation with various reagents. Only the combination of RA and TPA resulted in a catecholaminergic phenotype with pronounced dopaminergic features such as cell sensitivity to the neurotoxin MPP+ (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridinium ion), expression of dopamine transporter, and expression of tyrosine hydroxylase. After 7 days of differentiation, morphological and biochemical criteria were controlled (Fig. 1) . Undifferentiated SH-SY5Y cells exhibited short neurites during the growth phase (Fig. 1A) . After exposure to RA and TPA, an induction of extensive neurites outgrowth was observed (Fig. 1B) . TH catalyzes the rate-limiting step in the synthesis of dopamine (DA) and other catecholamines making TH the marker of choice for dopaminergic neurons. Therefore, change in TH was evaluated by western blot at the end of the differentiation process. A significant increase in the immune content of TH in differentiated cells was observed as compared to undifferentiated cells (representative western blot in Fig. 1C ). In conclusion, following this differentiation protocol, SH-SY5Y cells can be differentiated into TH-expressing cells with catecholaminergic phenotype, probably not strictly dopaminergic, but with pronounced dopaminergic features (Pregraves et al., 2004) .
Cell viability assays
Differentiated SH-SY5Y cells were exposed during 7 days to increasing concentrations of natural uranium, from 0.1 to 1000 μM in cell culture medium and cell viability was determined by measurement of ATP content (Fig. 2) . Cell viability assays enabled to determine the uranium concentrations that were further used to study uranium subcellular distribution. Three representative concentrations were selected, (i) non-cytotoxic concentrations (1 and 10 μM), (ii) a concentration at the inflection point of the curve (125 μM), representing the threshold of observable cytotoxic effects, and (iii) a moderately toxic concentration inhibiting 15% of cell viability (250 μM).
One of the main results of this study is that observable effects on cell viability after 7-day continuous exposure to natural uranium appears only at high uranium concentrations, greater than 100 μM. This result is in agreement with the relatively low cytotoxicity of uranium reported for various cell models. For example, in LLC-PK1 renal cells exposed for 24 h to uranium-bicarbonate, cytotoxic effects were observed only for concentrations greater than 700 μM (Mirto et al., 1999) . In NRK-52E normal renal tubular epithelial cells, the concentration leading to 50% loss of viability was 450 μM for 24 h exposure to uranium-bicarbonate (Carrière et al., 2004) . In primary rat cortical neurons, 24 h continuous exposure to depleted uranium, in uranyl acetate form, resulted in minimal effects on viability and morphology, with observable effects beginning only for uranium concentrations greater than 100 μM (Jiang et al., 2007) . Rouas et al. (2010) compared the cytotoxicity of depleted uranium on three human tumor cell lines, HEK-293 kidney cells, Hep-G2 liver cells, and IMR-32 neuroblastoma cells, showing in all cases that cytotoxic effects appeared only for exposure concentrations greater than 300 μM after either 24 or 48 h. In UMR-106 osteosarcoma cells, 50% loss of viability was observed after a 24 h exposure to 390 μM of natural uranium bicarbonate (Pierrefite-Carle et al., 2017) . We also previously observed, by measuring intracellular ATP, low uranium toxicity in HEK-293 renal cells and A549 lung cells with a half maximal inhibitory concentration reached at 500 μM of uranium after 24 and 48 h of exposure respectively Malard et al., 2005) . These values have to be compared to the concentration of uranium in physiological fluids after human exposure. In normal individuals, uranium concentrations in the blood have been measured in the order of 5-10 ng.L −1 (0.02 to 0.04 nM), and up to around 100 ng.L −1 (0.4 nM) after occupational exposure (Byrne and Benedik, 1991; Dang and Pullat, 1993) . These uranium concentrations measured in human blood are several orders of magnitude below the first observable effects on cell viability in vitro. However, the low cytotoxicity of natural uranium does not exclude more subtle effects on neurological functions.
Uranium subcellular distribution
Micro-PIXE experiments were carried out on terminally differentiated SH-SY5Y cells after 7-day continuous exposure to natural uranium at 0, 1, 10, 125 and 250 μM. In control cells and cells exposed to 1 μM, uranium content was below the limit of detection of micro-PIXE of about 1 fg per cell. Representative examples of intracellular uranium distribution for the other three exposure conditions are illustrated in Figs. 3-5. In total, 18 cells exposed to 10 μM, 26 cells exposed to 125 μM, and 13 cells exposed to 250 μM of uranium were analyzed by micro-PIXE.
The micro-PIXE combined to epifluorescence correlative microscopy approach enabled to precisely define the intracellular distribution of uranium in the nucleus and cytoplasm areas, respectively. For uranium exposure concentrations from 10 to 250 μM, uranium is localized in the cytoplasm (Figs. 3-5) , and never detected in the nucleus (Fig. 6) . Moreover, within the cytoplasm, uranium is not homogeneously distributed but rather accumulates in perinuclear sub-regions of the cytoplasm (Figs. 3-5) , probably within organelles. Single cell analysis also reveals that uranium levels are surprisingly variable from one cell to another one, as illustrated in Fig. 4 where the imaging of uranium in two adjacent cells shows a strong signal for the cell on the right of the image, and a much lower signal for the cell on the left. This inter-cellular variability is also exemplified by the large standard deviation found for the calculation of the mean uranium concentrations in single cells (Table 2) . On the other hand, potassium is uniformly distributed within the whole cell as expected for this ubiquitous intracellular element (Figs. 3-5) . Potassium uniform distribution throughout the whole cell is a good marker of a correct preservation of native element distributions during sample preparation (Perrin et al., 2015) . Potassium is present in cells as a highly diffusible ion, rendering its distribution very sensitive to osmotic changes during sample preparation that may A. Carmona et al. Neurotoxicology 68 (2018) 177-188 remove it, together with other diffusible elements, out of the cells. Previous experiments using micro-analytical methods have also reported uranium distributions in singles cells. The first observations were carried out by transmission electron microscopy (TEM) since uranium can form electron-dense precipitates easily detected by TEM. This is the case for example in the study of NRK-52E kidney cells cultured with high uranium concentrations, uranium electron-rich structures were located either inside and outside the cells (Carrière et al., 2004 and 2008) . Intracellular and extracellular uranium precipitates were also evidenced by TEM in UMR-106 osteosarcoma cells after 300 μM uranium exposure, but not at lower concentration, such as 100 μM (Pierrefite-Carle et al., 2017). In these cells, uranium precipitate was identified as meta-autunite using Extended X-ray Fine Structure Spectroscopy (EXAFS), as also predicted from theoretical modelling of simulated intracellular human biological fluid (Sutton and Burastero, 2004) . Uranium precipitates were present in intracellular vesicles, such as lysosomes, multi-vesicular bodies or auto-phagosomes (PierrefiteCarle et al., 2017) . In our study, we did not observe such intracellular precipitates probably because the exposure concentrations were below 300 μM and the speciation of uranium in the extracellular medium was defined to avoid precipitation. This conclusion is based on micro-PIXE images (Figs. 3-8) showing that uranium is not present as dense clusters in cells such as observed for example in the case of insoluble cobalt micro-particles ) but rather as a soluble element such as observed in the studies of the intracellular distribution of soluble cobalt chloride (Bresson et al., 2013) . However, it cannot completely be ruled out that uranium may be partially present in cells as small precipitates that may not have been detected by micro-PIXE.
The imaging of intracellular soluble forms of uranium in cells requires micro-analytical methods with better sensitivity than TEM. The subcellular distribution of soluble uranium could be investigated owing to secondary ion mass spectrometry (SIMS) imaging. Using this technique, soluble uranium was detected in the nucleus of HepG2 liver cancer cells after exposure to 10 and 50 μM, and in the nucleus of IMR32 neuroblastoma cells after exposure to 50 μM of depleted uranium nitrate (Rouas et al., 2010) . These results were recently confirmed by the same research group, showing that in HepG2 cells uranium was rapidly incorporated into the nucleus (Guéguen et al., 2015) . However, a very different subcellular distribution of uranium was described in renal cells from a rat model of uranium-induced acute renal toxicity as imaged using synchrotron radiation X-ray fluorescence (SRXRF) (Homma-Takeda et al., 2015) . In this latter study, uranium was present only in the cytoplasm of the renal cells, while it was found in the nucleus only for few necrotic cells. Our results are in good agreement with the subcellular distribution of uranium described in renal cells and imaged using SRXRF. In addition, although obtained at higher uranium exposure conditions (500 μM), uranyl-specific antibodies designed for cell imaging by immuno-fluorescence microscopy also clearly indicated the accumulation of uranium in defined cytoplasmic regions of renal cells (Reisser-Rubrecht et al., 2008) . Only few cells exhibited a very low, maybe non-specific, immunofluorescence staining in the nucleus, and this despite the high exposure conditions (500 μM). In our study, we did not observe uranium in the nucleus of differentiated SH-SY5Y cells with a detection limit around 1 fg/cell, but instead uranium was located only in the cytoplasm for all three exposure concentrations, 10, 125 and 250 μM. Compared to SIMS imaging results, such differences in uranium subcellular distribution might be explained by the conditions of sample preparation. For SIMS imaging, cells were chemically fixed with 2.5% glutaraldehyde, dehydrated in ethanol, and permeabilized with ethanol/epon mixture. Aldehyde fixation, alcohol dehydration and cell permeabilization are invasive methods known to drastically modify element distributions in cells, especially for soluble elements (Chwiej et al., 2005; Hackett et al., 2011; Roudeau et al., 2014; Perrin et al., 2015) . Denaturating sample preparation conditions used for SIMS imaging could explain why uranium was not observed in the cytoplasm. For our micro-PIXE study, and for SXRF imaging of renal tissue sections (Homma-Takeda et al., 2015) , samples were processed using non denaturating conditions. In our study, cells were processed using cryogenic protocols consisting in fast cryofixation and controlled freezedrying, a methodology validated to preserve the native distribution of the intracellular elements, including diffusible elements (Perrin et al., 2015) .
Quantitative analysis of micro-PIXE data enabled to determine uranium content in single cells after exposure to the selected concentrations of natural uranium (Table 2) . These results showed that the intracellular content of uranium in the cytoplasm increased with the rise of the extracellular uranium concentration, but not proportionally. Intracellular uranium content was lower than the limit of detection (< 1 fg) in control cells that were cultured without uranium, or in cells exposed to 1 μM of natural uranium. After 7-day continuous exposure to 10 μM, uranium was detected in cytoplasmic regions (34 ± 28 fg/cell), and not in the nucleus area where uranium content was below the limit of detection (< 1 fg). After 7-day continuous exposure to 125 μM, uranium content increased considerably in the cytoplasm (1297 ± 1523 fg/cell), with a 38 fold rise in the cytoplasmic content although the extracellular uranium concentration increased only 12.5 times (from 10 μM to 125 μM). After 7-day continuous exposure to 250 μM, a 1.5 fold rise in uranium intracellular content was measured (1908 ± 1207 fg/cell) compared to the 125 μM exposure, roughly proportional to the increase in extracellular concentration by a factor two. These results suggest a two-steps uptake of uranium. At 10 μM uranium exposure, a non-cytotoxic concentration (Fig. 2) , the intracellular uranium content is very low. This result reflects a correct function of cellular mechanisms of defense through restrained uptake, efficient efflux, or both mechanisms. At higher exposure concentrations, the cellular mechanisms responsible for uranium uptake seem to be overwhelmed, resulting in much higher intracellular content. This two-steps behavior for uranium intracellular accumulation could be attributed to the activation of different uptake pathways depending on uranium extracellular concentration, as also suggested from uranium isotopic fractionation (Paredes et al., 2016 (Paredes et al., , 2018 . Fig. 6 . Examples of micro-PIXE spectra from sub-cellular areas, nucleus (black line) and cytoplasm (red line), extracted from single cells exposed to (A) 10 μM, (B) 125 μM, and (C) 250 μM uranium. These spectra show that uranium is only detected within the cytoplasm, for the three exposure conditions.
Table 2
Uranium content in the cytoplasmic area of single differentiated SH-SY5Y cells after 7-day continuous exposure to 10, 125, and 250 μM of natural uranium (LOD: limit of detection = 1 fg). Another striking result of the quantitative analysis of the data is the high inter-cellular variability of uranium content, as illustrated by the large standard deviation of the mean obtained for all three exposure conditions (Table 2 ). This observation is also illustrated by the very different uranium contents in two adjacent cells from the same sample (Fig. 4) . These results seem to be rather unexpected considering that SH-SY5Y cells were fully differentiated, showing limited growth compared to undifferentiated cells, and should therefore represent a quite uniform population in terms of protein expression profile. Also, since the cells were exposed continuously to uranium for a 7-day period of time, one could expect that all the cells would accumulate comparable intracellular uranium content, reaching stable values. However, clonal populations of mammalian cells cultured in vitro often display phenotypic heterogeneity due to spontaneous switches, even in homogeneous environments, depending on the phenotypic intrinsic robustness of the cells (Stockholm et al., 2007) . Another explanation for this intercellular variability of uranium content could be that the differentiation protocol led to heterogeneous phenotypes at the single cell level, although when measuring the average effect of differentiation, TH expression, it results in the expression of the catecholaminergic phenotype. This variability has probably multiple origins that are difficult to explain with our data, however, identifying these origins would bring valuable information to understand the molecular mechanisms involved in the modulation of cell susceptibility to uranium uptake and toxicity.
In order to identify the subcellular organelle(s) that might be responsible for uranium accumulation a correlative microscopy approach was performed to label and identify lysosomes and Golgi apparatus in cells before performing micro-PIXE analysis. Cells were exposed to 125 μM uranium for a 7-day period following the previously described protocol. These preliminary results confirmed that uranium was located in the perinuclear region of the cells (Figs. 7-9 ). In cells exposed to uranium and labeled with CellLight RFP-lysosome reagent, the co-localization of uranium with the lysosomes was only partial as illustrated in Fig. 7 . Uranium was in part overlapping with the fluorescent labelling suggesting that the lysosomes might contain some uranium but the fact that the co-localization is only partial also suggest that the lysosomes might not be the main organelle for uranium accumulation. On the other hand, a partial co-localization of uranium with the Golgi apparatus was also observed (Fig. 8) . The results correlative microscopy for Golgi apparatus labelling suggest two possibilities; first uranium could be located within the Golgi apparatus and within another or several other organelles, or second, uranium is not located in the Golgi apparatus but the spatial resolution of the micro-PIXE is not good enough to strictly identify its localization. In order to check these hypotheses we exposed cells to brefeldin A (BFA), a disruptor of the Golgi apparatus (Fig. 9) . In previous studies using a similar methodology (Carmona et al., 2010) , we identified the Golgi apparatus as the main organelle for manganese accumulation in PC12 cells. In the study of manganese the exposure to BFA resulted in the entire redistribution of manganese from the perinuclear region, identified as the Golgi apparatus, to the broad cytoplasmic region (Carmona et al., 2010) . In the present study a very different result was obtained. BFA exposure resulted in the effective disruption of the Golgi apparatus as illustrated by the broad cytoplasmic distribution of the Golgi-GFP labeling (Fig. 10A ) but uranium distribution remained located to a narrow region of the cytoplasm (Fig. 10E ). This last result strongly indicates that the Golgi apparatus is not the main organelle for uranium accumulation in cells. Further studies are however required to identify more precisely the intracellular organelle(s) responsible for uranium accumulation.
Modulation of dopamine-related genes following uranium exposure
Using real-time quantitative RT-qRT-PCR analysis, the expression of dopamine-related genes was studied in uranium-treated SH-SY5Y cells and compared to unexposed cells (Table 3) Overlay image of Golgi-GFP CellLight, nucleus and uranium distribution. These images are representative of an analysis performed on n = 3 cells. Fig. 10 . MAO-B protein levels in differentiated SH-SY5Y cells after 7-day continuous exposure to 10, 125 or 250 μM of natural uranium (mean ± SD). MAO-B protein levels were measured using ELISA assay and normalized to the total amount of extracted proteins (ng/mg protein). The relative changes were compared to controls (**p < 0.01,***p < 0.001). Three independent biological repeats were carried out, each repeat was analyzed in triplicate by ELISA. Table 3 RT-qRT-PCR analysis of dopamine-related genes in differentiated SHSY-5Y cells after 7-day continuous exposure to 10, 125 and 250 μM of natural uranium. Gene expression was compared to the respective untreated control. The expression levels of the target gene were normalized to the expression level of ACTB (beta actin) and GAPDH (Glyceraldehyde-3-Phosphate Dehydrogenase) genes. Three independent biological repeats were carried out, and each replicate was analyzed by RTqRT-PCR in triplicate. Mean and SD of the relative normalized expression are given. *p-value < 0.05; ***p-value < 0.001.ND: not detected. manner, the relative normalized expressions compared to control being respectively 0.63, 0.27 and 0.23. TH gene expression was also decreased, although the difference was statistically significant only after 10 μM exposure (p < 0.05). VMAT2 vesicular monoamine transporter 2 (SLC18A2 / VMAT2), and dopamine receptor D1 (DRD1) gene expression were not statistically significantly modified upon uranium exposure. Dopa decarboxylase (DDC) gene expression was increased by a factor 1.4 but only after high (250 μM) uranium exposure (p < 0.001). The signals obtained for DAT dopamine transporter (SLC6A3) and dopamine receptor D3 (DRD3) were too low to be detected. These results suggest that MAO-B is the main catecholamine related gene being modified by U exposure. Therefore, we quantified MAO-B protein levels using enzyme-linked immunosorbent assay to confirm whether the modification of gene expression is also present at the protein level (Fig. 10) . Compared to controls, MAO-B protein levels were respectively 0.71, 0.27 and 0.37 following 10, 125 and 250 μM U exposure. These values are very close to the ones found for MAO-B inhibition of gene expression with levels of respectively 0.63, 0.27 and 0.23 following 10, 125 and 250 μM U exposure.
Animal studies have shown that exposure to uranium can affect neurotransmitter pathways, in particular the cholinergic and monoamine systems (Bussy et al., 2006; Barber et al., 2007; Briner et al., 2008; Bensoussan et al., 2009; Dinocourt et al., 2015) . For instance, acetylcholinesterase activity and monoamine metabolism were disturbed in male rat brains after long-term chronic exposure to uranyl nitrate in drinking water (Bussy et al., 2006) . In this study, acetylcholinesterase activity was transitionally perturbed in the cerebellum after 6 months of exposure but was unaffected in the striatum, hippocampus and frontal cortex. More pronounced effects were observed on monomamine metabolism in this same study. After 1.5 months of uranium exposure, dopamine level increased in the hypothalamus but not in other brain regions such as the striatum. After 9 months of exposure, a significant decrease of DOPAC (3,4-dihydroxyphenylacetic acid) was observed in the striatum, while dopamine and other monoamines and dopamine metabolites were unchanged. Our results, showing a decrease in MAO-B gene expression in TH-expressing cells continuously exposed to uranium during a 7-day period (Table 3) could be related to the reported decrease in DOPAC level in the striatum after chronic uranium exposure of rats (Bussy et al., 2006) . Both studies point out a specific sensitivity of dopamine catabolism pathway to uranium exposure. MAO-B primarily serves the catabolism of phenethylamine (PEA), a monoamine alkaloid that regulates the release of norepinephrine and dopamine, but also contributes to the degradation of other trace amines and dopamine (Bortolato and Shih, 2011) . Since dopamine is transformed into its metabolite DOPAC through MAO-B catalyzed deamination, depletion of MAO-B gene transcription and potentially of MAO-B protein expression could result in DOPAC decrease. More generally, changes in MAO-B protein expression can have devastating effects on the brain and behavior by lowering or raising neurotransmitter levels. Deficit in MAO-B protein expression or activity has been associated with a broad range of neurological disorders such as psychotic disorders, depression, alcoholism, impulsivity, and neurodegenerative diseases (Bortolato and Shih, 2011) . It is also interesting to note that neurotoxic metals such as manganese and lead can decrease broad MAO activity in animal models (Zhang et al., 2003; Jaya Prasanthi et al., 2005; Chand Basha et al., 2014) . However, these experiments were not designed to differentiate between metal effects on MAO-A or MAO-B variants, or on MAO decreased gene expression vs MAO inhibition of protein activity.
The reported results on brain dopamine content of animal models exposed to uranium are however variable (Bussy et al., 2006; Barber et al., 2007; Briner et al., 2008) . As previously mentioned, dopamine levels increased only in the hypothalamus after 1.5 month exposure but were unchanged in other brain regions after chronic exposure to uranium following 1.5, 6 and 9 months (Bussy et al., 2006) . In another study, striatal dopamine content was at the contrary reduced by 30% three days after intramuscular injection of 1 mg/kg of uranyl acetate, but returned to control levels after 7 days (Barber et al., 2007) . In a 2-week study of mice exposed to 6 mg U/kg/day (depleted uranyl acetate), exposure to uranium significantly increased tyrosine and decreased DOPA, norepinephrine, and epinephrine but had no significant effect on dopamine or homovanillic acid (Briner, 2008) . In our study, dopamine content was not directly measured, but TH gene expression was statistically significantly reduced after 7-day exposure to 10 μM uranium. This change was not reproduced for higher uranium concentrations (125 and 250 μM). The variability of the results reported in the literature on dopamine content might reflect that uranium exposure could alter the dopaminergic system but with different outcomes, depending on uranium exposure conditions (acute vs chronic), speciation and isotopic composition of the administrated uranium, animal models, and differential expression of multiple molecular targets in the complex dopamine system. In our study, the lack of a clear alteration of dopamine-related gene expression, except for MAO-B, could be linked to the phenotypic heterogeneity, as indicated by the highly variable inter-individual uranium content. More generally, it could be associated with a non-specific interaction of uranium with various molecular targets, including some, but not only, involved in the dopamine system. That said, it emphasizes the importance of the reduction of MAO-B expression after uranium exposure. This result highlights a specific and robust change, reproduced in 3 independent assays each performed in triplicate, and for 3 exposure conditions, at the gene and protein expression levels, reflecting different stages of toxicity (10, 125 and 250 μM).
Conclusions
It is known from the literature that uranium exposure results in uranium circulating in the blood and that a small part of circulating uranium will reach the brain, causing neurological impairments. However, very few data have been published to evaluate the thresholds of exposure for observable neurological effects as well as the molecular mechanisms involved in uranium neurotoxicity. In this study we showed that after 7-day continuous exposure to natural uranium a low cytotoxicity was observed on dopamine producing cells. Toxic concentrations were greater than 125 μM, far from the expected uranium concentrations in blood even after occupational exposure. The low cytotoxicity of uranium might be explained, at least in part, by its limited cellular uptake, especially at low exposure concentration since this element amount was below the limit of detection (< 1 fg) in cells exposed to 1 μM of uranium during 7 days, and detected in low content (34 fg / cell) after exposure to the non-cytotoxic concentration of 10 μM. Cytotoxic effects only occurred for exposure concentrations higher than 100 μM when uranium was detected in significant amount in cells (> 1000 fg / cell). Our results also suggest a differential cellular uptake of uranium after low and high uranium exposure conditions. At low uranium exposure concentrations (1 and 10 μM), uranium incorporation is very limited suggesting controlled mechanisms of uptake and/or efflux, while at high uranium exposure concentrations (125 and 250 μM), this controlled mechanisms are less effective resulting in high uranium intracellular content, not proportional to the increase in exposure concentration. Another major result is that whatever the exposure concentration, up to 250 μM during 7 days, uranium content in the nucleus of differentiated SH-SY5Y cells was lower than the detection limit. Uranium was found only in the cytoplasm, restricted to perinuclear sub-regions. Uranium cytoplasmic perinuclear distribution might reflect interactions with perinuclear organelles yet to be determined. An intriguing result of this study is the high inter-cellular variability with cells incorporating almost any uranium even at high exposure concentrations during 7 days. Although this result is difficult to understand with the available data it emphasizes the importance of single cell analysis experiments. This intercellular variability in uranium uptake may reflect differences in cell differentiation at the single cell level, and/or other individual phenotypes which are critical in uranium uptake and subsequent toxicity. Although uranium was cytotoxic only at high concentrations (> 125 μM), some modifications of expression in genes involved in monoamine metabolism were observed for 10 μM exposure. The main result was obtained for gene expression of MAO-B, being statistically significantly reduced after 10, 125 and 250 μM uranium exposure. This effect was also evidenced at the protein level as confirmed by ELISA quantification of MAO-B. This result might explain why DOPAC is decreased in rats chronically exposed to uranium in drinking water (Bussy et al., 2006) . This last study and ours indicate that the catabolism of dopamine could be a specific target for uranium neurotoxicity. More generally, our results indicate that uranium exposure could modulate the metabolism not only of dopamine but also of other important substrates for MAO-B activity such as PEA and other trace amines. Further studies are now needed to identify the organelle (s) of uranium accumulation, and to investigate whether verylow levels of uranium could interact with MAO activity in dopaminergic and other neuronal cell types.
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